Nature Reviews Cardiology

Papers
(The H4-Index of Nature Reviews Cardiology is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
LIPC variant in combined hypocholesterolaemia956
Antibody treatment to deplete transthyretin amyloid deposits in the heart471
Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%469
Intravascular imaging improves outcomes423
Bariatric metabolic surgery more effective than GLP1R agonists in preventing congestive HF412
Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals407
Aggregation of big tau disrupts microtubules and causes diastolic dysfunction401
The City Heartbeat Index as a benchmarking tool for urban cardiovascular health375
Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults319
Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease308
Takotsubo syndrome: pathophysiological insights and innovations in patient care307
Optimizing cardiovascular pharmacotherapy in older adults with frailty306
Genetics and mechanisms of thoracic aortic disease297
Alternative defibrillation strategies improve outcomes270
Think Aorta: aortic dissection awareness and perspectives from the patient260
Detection of subclinical hypertrophic cardiomyopathy247
Base editing and silencing of PCSK9 shows clinical promise in humans236
Drug-coated balloon angioplasty for coronary and peripheral artery disease: latest evidence and clinical indications235
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale235
Defining iron deficiency in patients with heart failure231
HFpEF and MASLD: converging mechanisms and clinical implications229
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice229
Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course211
Hallmarks of cardiovascular ageing209
A fatty acid from mother’s milk drives cardiomyocyte maturation in newborn mice198
Preparticipation screening reduces SCD in young athletes171
LDL-cholesterol lowering with obicetrapib163
No benefit of apoA-I infusion after myocardial infarction162
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk157
Catheter ablation improves outcomes in patients with AF and end-stage HF150
Colchicine in acute coronary syndromes: the present and the possible future149
Increased degradation of desmosomal proteins in ACM142
CSDE1 regulates LDL receptor levels138
Tailored therapeutics for cardiomyopathies135
Targeting immune cell recruitment in atherosclerosis132
Extracellular matrix in vascular homeostasis and disease132
Cardiac lymphatic dysfunction and repair in cardiovascular disease128
Graded exercise therapy should not be recommended for patients with post-exertional malaise128
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes128
Decongestion in heart failure: medical and device therapies122
Reactive oxygen species in hypertension118
The oral microbiome in the pathophysiology of cardiovascular disease115
Donor macrophages influence rejection of transplanted hearts115
Modelling pre-eclampsia and its cardiovascular effects114
Reply to ‘Graded exercise therapy should not be recommended for patients with post-exertional malaise’112
Cardiac sarcomere turnover by unidirectional replacement of proteins110
Bempedoic acid prevents cardiovascular events in statin-intolerant patients109
Unlocking excellence in health care: the power of inclusive and sensitive language in medicine109
Promising novel siRNA for the treatment of hypertension108
Semaglutide is beneficial in patients with HFpEF and obesity106
Calculation methods for LDL cholesterol are evolving tools for accuracy in lipidology103
Evidence does not support the reduction of added sugar intake from all food sources101
Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials99
RNA interference lowers triglyceride levels99
Local calcium dynamics and signalling in cardiomyocytes98
Global epidemiology of heart failure97
An epigenome editing approach induces durable silencing of Pcsk995
Single-cell profiles of CHD and CM91
Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight88
Simvastatin protects against endothelial dysfunction via epigenetic mechanisms86
The role of the molecular autopsy in sudden cardiac death in young individuals83
Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis80
Development of a miniature, bioresorbable, light-activated pacemaker78
The gut metabolite imidazole propionate is a potential biomarker of and therapeutic target for atherosclerosis76
Heart transplantation: advances in expanding the donor pool and xenotransplantation73
Digital screening and decision-support tools in equitable preventive cardiology73
Tricuspid valve disease: updates on diagnostic imaging and intervention72
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology71
Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target70
Efferocytosis in atherosclerosis70
1.1345970630646